Unani Approach to Graded Management of Thrombosis in COVID-19
Patients

Zikra      Tahseen. A; Ghulamuddin      Sofi; Arisha      Shahid; Sofia; Shahila      Aazam

doi:10.2174/2215083810666230914103404

Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.

Abstract

Background and Objectives: This study aimed to explore the treatment of thrombosis caused by COVID-19 with the drugs used in Unani medicine. Unani medicine has rich literature that mentions the pathogenesis, causes, and treatment of the diseases caused by obstruction of vessels. The study explores various drugs with actions that complement the resulting thrombolytic actions and details the rational treatment plan following the Unani medicine protocol.

Methodology: The literature regarding thrombosis was surveyed from indexed online journals. The concept of thrombosis in Unani literature was surveyed from the source texts of Unani medicine. The treatment strategy and drugs with anti-thrombotic actions were explored, and a rational graded management of thrombosis in COVID-19 patients was presented that forms the general treatment plan of Unani medicine in patients with thrombosis.

Results: The study observed that several Unani drugs from natural sources are mentioned for deobstruent action. De-obstruent action is a composite action that encompasses anti-inflammatory, disintegratory, blood detoxification, and other activities. There was a concordance with the concept of thrombolytic action, as mentioned in conventional medicine. When rationally used, these drugs form a graded treatment of thrombosis associated with COVID-19.

Conclusion: There is a potentially successful treatment plan with several de-obstruent drugs in Unani medicine that may be explored to treat thrombosis associated with COVID-19.

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/2215083810666230914103404	Print ISSN 2215-0838
Publisher Name Bentham Science Publisher	Online ISSN 2215-0846

Current Traditional Medicine

Unani Approach to Graded Management of Thrombosis in COVID-19 Patients

Abstract Play Pause

Related Journals

Related Books

Abstract